Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Pathway Type:



Showing 51 - 60 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0124624

Pw126107 View Pathway

1-Naphthol Metabolism Test

Metabolic

SMP0144686

Pw146354 View Pathway

1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) Drug Metabolism Action Pathway

Drug Action
  • 1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))

SMP0063713

Pw064700 View Pathway

1.      Barrier

Signaling

SMP0121244

Missing View Pathway

1.      Barrier 1562761104

Signaling

SMP0121256

Missing View Pathway

1.      Barrier 1564688413

Signaling

SMP0000575

Pw000551 View Pathway

11-beta-Hydroxylase Deficiency (CYP11B1)

11-beta-Hydroxylase Deficiency, also called congenital adrenal hyperplasia (CAH), is an autosomal recessive disorder and caused by a defective 11-beta-hydroxylase. 11-beta-hydroxylase catalyzes the conversion of cortexolone into cortisol which is useful for maintaining blood sugar levels and suppressing inflammation. This disorder is characterized by a large accumulation of cortexolone in the endoplasmic reticulum (ER). Symptoms of the disorder include abnormality of hair growth rate and menstrual cycle. It is estimated that 11-beta-hydroxylase deficiency affects 1 in 100,000 to 200,000 newborns.
Disease

SMP0125800

Pw127367 View Pathway

11-beta-Hydroxylase Deficiency (CYP11B1)

11-beta-Hydroxylase Deficiency, also called congenital adrenal hyperplasia (CAH), is an autosomal recessive disorder and caused by a defective 11-beta-hydroxylase. 11-beta-hydroxylase catalyzes the conversion of cortexolone into cortisol which is useful for maintaining blood sugar levels and suppressing inflammation. This disorder is characterized by a large accumulation of cortexolone in the endoplasmic reticulum (ER). Symptoms of the disorder include abnormality of hair growth rate and menstrual cycle. It is estimated that 11-beta-hydroxylase deficiency affects 1 in 100,000 to 200,000 newborns.
Disease

SMP0124916

Missing View Pathway

123

Disease

SMP0125957

Missing View Pathway

1234

Protein

SMP0145343

Pw147011 View Pathway

13-cis-Retinoic acid Drug Metabolism Pathway

Metabolic
Showing 51 - 60 of 131351 pathways